Zhenge Biotech – a Shanghai-based contract development and manufacturing organization (CDMO) for large molecule drugs – has raised $70 million in Series B funding led by Qiming Venture Partners and IDG Capital.
CMB International, Lyfe Capital, and GT Capital are among the re-upping investors, according to a statement. They are joined by several government-related investment entities, such as Shanghai Financial...
China’s MSA Capital has joined a $30.5 million round for Saudi Arabian B2B services marketplace Sary as part of a deepening Asia-Middle East agenda.
Huoban.com, a Chinese zero-code application building platform has raised $17 million in Series B funding led by 5Y Capital and Sequoia Capital China. Challenjers Capital also took part in the round.
Apollo Management has submitted a A$4 billion ($3.1 billion) bid for the wagering and media and gaming services businesses of Tabcorp Holdings, Australia’s largest gambling company.
David Swensen, head of the Yale University endowment who pioneered a new approach to institutional investment management, has died aged 67 following a long battle with cancer.